Clear Harbor Asset Management LLC acquired a new stake in Cigna Group (NYSE:CI – Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 2,270 shares of the health services provider’s stock, valued at approximately $626,000.
A number of other institutional investors also recently modified their holdings of the stock. Assetmark Inc. increased its stake in shares of Cigna Group by 10.0% during the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after purchasing an additional 5,963 shares during the last quarter. Mystic Asset Management Inc. acquired a new stake in shares of Cigna Group in the 2nd quarter valued at $2,808,000. HighTower Advisors LLC boosted its holdings in Cigna Group by 402.7% in the second quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock worth $97,701,000 after purchasing an additional 283,897 shares in the last quarter. KBC Group NV boosted its holdings in Cigna Group by 6.4% in the second quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock worth $104,768,000 after purchasing an additional 22,978 shares in the last quarter. Finally, Handelsbanken Fonder AB increased its position in Cigna Group by 12.1% during the second quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider’s stock worth $22,833,000 after buying an additional 8,960 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
Cigna Group Stock Down 0.5%
CI stock opened at $276.19 on Monday. The stock has a market capitalization of $72.98 billion, a price-to-earnings ratio of 11.43, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29. The company has a 50-day moving average of $284.20 and a two-hundred day moving average of $281.45. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76.
Cigna Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s payout ratio is 25.82%.
Insider Activity at Cigna Group
In other news, insider Nicole S. Jones sold 2,677 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 23,012 shares of company stock valued at $6,386,550 over the last three months. 0.60% of the stock is owned by company insiders.
Analysts Set New Price Targets
CI has been the topic of several recent research reports. Mizuho raised their target price on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a report on Monday, June 8th. The Goldman Sachs Group increased their price objective on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Royal Bank Of Canada raised their price objective on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Barclays boosted their target price on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Finally, Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their price target for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and a consensus target price of $339.45.
View Our Latest Stock Analysis on Cigna Group
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
- Five stocks we like better than Cigna Group
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
